Top Section/Ad
Top Section/Ad
Most recent
Shareholders sell down holdings in AutoStore and Orsted, as shipping company opens books ahead of Athens parallel listing
Deeply discounted financing allows embattled iron ore miner to restart Ukrainian production and shares to resume trading
International investors take most of the book for the first time as Zabłocki's investment firm says it expects to make no further sales
Food systems company’s largest shareholder raises €324m after shares rise on strong results and buyback
More articles/Ad
More articles/Ad
More articles
-
German real estate company Vonovia priced a €1bn accelerated capital raise on Thursday to take advantage of possible growth opportunities arising from the Covid-19 pandemic. The deal was covered quickly and attracted enough demand to cover the transaction several times but execution was made complicated by a sell-off in US tech stocks on Thursday evening. -
Ryanair completed a non-pre-emptive share placing on Thursday evening to strengthen its balance sheet to withstand the next phase of the Covid-19 pandemic and to take advantage of growth opportunities. Despite analysts not thinking the company needed extra capital, sources said the company's CEO Michael O'Leary made a compelling case to investors for the need to boost its balance sheet.
-
September began with a bang for equity issuance, capped off on Wednesday by a mammoth €2.7bn share sale from Siemens Healthineers. However, the rush of deals is not just being driven by optimism. Bankers fear darker days returning.
-
Equity bankers and investors are preparing for a wave of emerging market equity issuance before the end of 2020, propelling hopes that the asset class will end the year on a high after being left behind so far this year.
-
Solar glass manufacturer Xinyi Solar Holdings raised HK$2.7bn ($343.5m) on Wednesday, after boosting the size of a primary share sale.
-
Siemens Healthineers, the German healthcare tech company, has sold €2.73bn of new stock in the largest block trade 2020 has seen so far to partly finance its $16.4bn acquisition of US cancer care solutions firm Varian. The consensus among ECM bankers is that it will be vital to execute transactions during the next few weeks, before a tempestuous US election and possible rises in Covid-19 cases spoil the party, write Sam Kerr and Aidan Gregory.
